InMode Ltd. (INMD) स्टॉक विश्लेषण

कंपनी का अवलोकन

InMode Ltd. (INMD) operates within the Healthcare sector, specifically focusing on the Medical Devices industry, where it designs, develops, manufactures, and markets minimally invasive aesthetic medical products. The company leverages proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies to serve markets in the United States, Europe, Asia, and internationally. With a total market capitalization of $867.38M, an annual revenue of $370.50M, and a workforce comprising 660 employees, InMode Ltd. maintains a substantial operational footprint in the global medical aesthetic landscape. These valuation and revenue figures indicate that the company holds a significant position within its niche, supported by a large employee base that facilitates the manufacturing and distribution of its specialized aesthetic medical solutions across diverse international regions.

वित्तीय स्वास्थ्य

The company reported a total revenue of $370.50M for the trailing twelve months, generating a net income of $93.83M and an EBITDA of $86.08M. The substantial gap between the revenue of $370.50M and the net income of $93.83M reveals a robust cost structure, suggesting that operating expenses and taxes account for a significant portion of the top line before reaching the bottom line. Free cash flow stands at $39.10M, which indicates that the company retains sufficient cash after capital expenditures to maintain financial flexibility for future operational needs or strategic investments. In terms of profitability metrics, the gross margin is 78.5%, reflecting high efficiency in production and supply chain management, while the operating margin is 25.0% and the profit margin is 25.3%, demonstrating that a quarter of every dollar in sales translates to operating profit and a similar amount reaches the bottom line after all expenses. The balance sheet shows a cash position of $555.33M against total debt of $8.23M, resulting in a debt-to-equity ratio of 1.20, which suggests a moderately leveraged but highly liquid financial structure where cash reserves significantly exceed debt obligations. Additionally, the current ratio of 9.88 indicates exceptional short-term liquidity, meaning the company possesses nearly ten times the current assets required to cover its current liabilities. Return on Equity is 13.5% and Return on Assets is 6.9%, metrics that reveal management's effectiveness in generating returns from shareholders' equity and utilizing the company's asset base to produce earnings.

मूल्यांकन आकलन

The trailing P/E ratio is 9.57, while the forward P/E is 8.94, implying that the market expects earnings growth that would lower the valuation multiple over the coming period. The price-to-book ratio stands at 1.27, indicating that the market values the company at a slight premium of 27% above its book value. Alternative valuation metrics include a price-to-sales ratio of 2.34 and an EV/EBITDA of 3.72, which suggest the company is valued at a moderate multiple relative to its sales and earnings power before interest, taxes, depreciation, and amortization. The 52-week high is $16.74 and the 52-week low is $12.72, providing a historical trading range that contextualizes current price movements relative to recent volatility. The beta value of 2.12 indicates that the stock exhibits more than double the volatility of the broader market, meaning price swings are significantly amplified compared to standard market indices.

Growth & Income

Revenue growth year-over-year is 6.1%, whereas earnings growth year-over-year is -63.5%, indicating that earnings are currently contracting at a much faster rate than revenue expansion. This divergence implies that while top-line sales are increasing, cost pressures or one-time expenses are disproportionately impacting the bottom line. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the company reinvests all its earnings into growth initiatives, research, and development rather than distributing cash to shareholders. Overall, the growth and income profile presents a scenario of moderate revenue expansion coupled with significant earnings contraction and a total absence of dividend income, relying entirely on capital appreciation and operational reinvestment for shareholder value.